๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interleukin-2: Evaluation of routes of administration and current delivery systems in cancer therapy

โœ Scribed by Mohamed A. Shaker; Husam M. Younes


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
354 KB
Volume
98
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

โœฆ Synopsis


Despite the fact that different administration routes and delivery systems have been used for interleukin-2 (IL-2) delivery, little has been reported regarding the most efficient strategies used to deliver IL-2 in a nontoxic, efficient, stable and safe manner. Systemic IL-2 administration has always been associated with rapid clearance and severe toxicity as a result of its narrow therapeutic index. Loco-regional IL-2 delivery, however, is used to localize IL-2 actions and activities into the vicinity of tumors and can result in an improved therapeutic outcome with much less side effects or toxicity. The purpose of this review is to report on the different properties and aspects of IL-2, including its mechanism of action, physicochemical properties, and structure which have an impact on the activity, stability and formulation of IL-2 dosage forms and delivery systems. In addition, advantages and limitations of the currently available techniques and strategies to deliver IL-2 will also be covered.


๐Ÿ“œ SIMILAR VOLUMES


Interferon-ฮณ therapy: Evaluation of rout
โœ Husam M. Younes; Brian G. Amsden ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 200 KB

Although different routes and delivery systems have been used to deliver interferon-g (IFN-g) for the treatment of a variety of viral and neoplastic diseases, little has been reported regarding the most efยฎcient and least toxic routes and drug delivery modes required to achieve these goals. To have

In vitro anti-tumor activity of eosinoph
โœ Licia Rivoltini; Mario Paolo Colombo; Giorgio Parmiani; Vincenzo Viggiano; Silvi ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 1004 KB

lnterleukin 2 (IL-2) administration is known to induce marked eosinophilia. To evaluate the potential role of eosinophils as anti-tumor effectors and t o understand the direct or indirect effects of IL-2 on eosinophils, the physical and functional characteristics of eosinophils obtained during IL-2

Trends in the safety of high dose bolus
โœ Udai S. Kammula; Donald E. White; Steven A. Rosenberg ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB ๐Ÿ‘ 2 views

## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #

A phase I study of interleukin-2 in chil
โœ Sherif Nasr; John McKolanis; Ray Pais; Harry Findley; Robert Hnath; Kathy Waldre ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 600 KB

The authors performed a Phase I study to assess the toxicity and hematologic effect of recombinant human interleukin-2 (rIL-2) in seven children with advanced malignancies. The rIL-2 was given as a bolus injection of 1 or 3 X lo6 U/m2/dose three times a week (Monday, Wednesday, and Friday) for 3 wee